Proof‐of‐concept trial of PP‐01 for mitigating cannabis withdrawal syndrome in participants with cannabis use disorder

Proof‐of‐concept trial of PP‐01 for mitigating cannabis withdrawal syndrome in participants with cannabis use disorder PP-01 Reduced Symptoms of Cannabis Withdrawal in a Randomized, Placebo-Controlled, Double-Blind, Proof-of-Concept Clinical Trial

The release as fetched from its publisher. pleopharma.com ↗